Actemra May Treat Severe COVID-19 Infections in Myeloma Patients, Case Report Suggests

Actemra (tocilizumab), a medicine approved for certain types of arthritis, may be effective in treating severe infections with the new coronavirus in people with multiple myeloma or other blood disorders, findings from a patient in China suggest. The case report also indicates that those with blood cancers may have atypical COVID-19 symptoms, like an absence of fever or cough. The study, “First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab,”…

You must be logged in to read/download the full post.